Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Environ Monit Assess ; 193(2): 82, 2021 Jan 23.
Artigo em Inglês | MEDLINE | ID: mdl-33486539

RESUMO

The aim of the present study was to examine the genotoxicity induced by water-soluble fractions of particulate matter (PM) and its potential relation with heavy metals. For this purpose, the genotoxicity induced on human peripheral lymphocytes by water-soluble PM2.5 (particles with aerodynamic diameter ≤ 2.5 µm) collected from the indoor air of various workplaces in Greece (n = 20), was examined by the Sister Chromatid Exchange (SCE) induction assay and assessed in relation to the concentrations of the heavy metals Cu, Pb, Mn, Ni, Co, Zn, Cr, and Cd. The number of SCEs per metaphase (SCEs/metaphase), as an indicator of genotoxicity, the proliferation rate index (PRI), as an indicator of cytostaticity, and the mitotic index (MI), as an indicator of cytotoxicity, were measured and assessed in three water-soluble fractions of PM2.5: the total water-soluble fraction WSA (filtered through 0.45 µm), the dissolved fraction WSB (filtered through 0.22 µm), and the non-chelexed dissolved fraction WSC (filtered through Chelex-100 resin). Results showed statistically significant number of SCEs/metaphase in all water-soluble PM2.5 fractions in relation to the control with large variabilities across the workplaces as a result of variations in indoor conditions, sources, and/or activities. The concentrations of genotoxicity were evaluated in terms of mass-normalized genotoxicity (SCEs/mg PM2.5), that represents the genotoxic potency of particles, and air volume-normalized genotoxicity (SCEs/m3 air), that reflects the inhalation risk for people working or spending much time in these microenvironments. Correlation and linear regression analyses were further employed in order to investigate the potential relationships between genotoxicity and the water-soluble concentrations of PM2.5-bounded heavy metals. According to the results, the highest mass-normalized genotoxicity values were found for PM2.5 from the photocopying center, whereas the highest air volume-normalized genotoxicity was found in tavern-2. Significant positive correlations between the genotoxicity and water-soluble metals were derived, highlighting the role that heavy metals play in the genotoxicity of indoor PM2.5. Among the targeted metals, Zn and Pb were found to be good predictors of the genotoxicity of water-soluble PM2.5.


Assuntos
Poluentes Atmosféricos , Metais Pesados , Poluentes Atmosféricos/análise , Poluentes Atmosféricos/toxicidade , Dano ao DNA , Monitoramento Ambiental , Grécia , Humanos , Metais Pesados/análise , Metais Pesados/toxicidade , Material Particulado/análise , Material Particulado/toxicidade , Água
2.
Artigo em Inglês | MEDLINE | ID: mdl-30595211

RESUMO

Cultured human lymphocytes were treated with vitamins K1 and B1, potential anticancer agents, either alone or in combination with irinotecan, a semisynthetic analogue of camptothecin. The frequency of sister chromatid exchanges (SCEs) was measured as an indicator of genotoxicity and the proliferation rate index (PRI) and mitotic index (MI) was measured as indicators of cytostatic effect. Vitamin K1 alone did not induce SCEs at the concentrations tested and combined with irinotecan does not increase SCE rates induced by irinotecan alone. Vitamin B1 significantly increased SCEs and, in combination with irinotecan, increased rates further (p < 0.05). Vitamin K1 decreased PRI and MI in combination with irinotecan, there were further increases in MI. At a low concentration, vitamin B1 reduced the levels of SCE and increased PRI induced by irinotecan. The use of these vitamins in combination with antitumor agents might reduce clinical side effects of the antineoplastics.


Assuntos
Antineoplásicos/farmacologia , Proliferação de Células/efeitos dos fármacos , Irinotecano/farmacologia , Linfócitos/efeitos dos fármacos , Índice Mitótico , Troca de Cromátide Irmã/efeitos dos fármacos , Tiamina/farmacologia , Vitamina K 1/farmacologia , Células Cultivadas , Combinação de Medicamentos , Humanos , Testes de Mutagenicidade/métodos
3.
Artigo em Inglês | MEDLINE | ID: mdl-24680952

RESUMO

We studied the effects of three newly synthesized steroidal derivatives of nitrogen mustards, alone or in combination with caffeine, on sister chromatid exchange (SCE) frequencies and on human lymphocyte proliferation kinetics. The agents have as alkylator functionalities either P-N,N-bis(2-chloroethyl)aminophenyl-buturate (CHL) or P-N,N-bis(2-chloroethyl)aminophenyl-acetate (PHE), esterified with a modified steroidal nucleus. An enhancement of SCE frequency was seen with compounds which contain either PHE or CHL as alkylators and are esterified with a steroidal nucleus having added a cholestene group in the 17-position of the D-ring. The exocyclic insertion of an -NHCO- group in the D-ring of the steroidal nucleus esterified with PHE (amide ester of PHE) gave a compound showing increased SCE frequency. Enhanced cytogenetic damage was observed when lymphocytes were exposed in vitro to caffeine. The compounds, alone or in combination with caffeine, caused a concentration-dependent increase in SCE frequencies and cell division delays, and caffeine was found to act synergistically with the steroidal alkylators.


Assuntos
Antineoplásicos Alquilantes , Cafeína , Núcleo Celular/metabolismo , Estimulantes do Sistema Nervoso Central , Aberrações Cromossômicas/induzido quimicamente , Linfócitos/metabolismo , Compostos de Mostarda Nitrogenada , Troca de Cromátide Irmã/efeitos dos fármacos , Adulto , Antineoplásicos Alquilantes/efeitos adversos , Antineoplásicos Alquilantes/agonistas , Antineoplásicos Alquilantes/farmacologia , Cafeína/efeitos adversos , Cafeína/agonistas , Cafeína/farmacologia , Núcleo Celular/genética , Núcleo Celular/patologia , Estimulantes do Sistema Nervoso Central/efeitos adversos , Estimulantes do Sistema Nervoso Central/agonistas , Estimulantes do Sistema Nervoso Central/farmacologia , Sinergismo Farmacológico , Feminino , Humanos , Linfócitos/patologia , Masculino , Compostos de Mostarda Nitrogenada/efeitos adversos , Compostos de Mostarda Nitrogenada/agonistas , Compostos de Mostarda Nitrogenada/farmacologia , Esteroides/efeitos adversos , Esteroides/agonistas , Esteroides/farmacologia
4.
Mutat Res ; 746(1): 1-6, 2012 Jul 04.
Artigo em Inglês | MEDLINE | ID: mdl-22464985

RESUMO

New compounds with potential antitumour activity were synthesised by combining nitrogen mustard with the steroidal skeleton, in an effort to improve specificity and at the same time reduce systemic toxicity. The steroidal part is aimed to serve as a biological platform enabling the alkylating moiety to approach its site of action by altering its physicochemical properties. The purpose of the present investigation was to evaluate these compounds for anti-neoplastic activity. The compounds tested have as alkylators either para-NN-bis(2-chloroethyl)-aminophenyl-butyrate (CHL) or para-N,N-bis(2-chloroethyl)-aminophenyl-acetate (PHE) esterified with a differently modified steroidal nucleus. The eight newly synthesised compounds were compared on a molar basis with respect to their ability to induce sister chromatid exchanges (SCEs) and to modify proliferation rate indices (PRI) in lymphocytic leukaemia P388 cells in mice in vivo. The life span of BDF1 mice inoculated with P388 leukaemia cells was also estimated (anti-leukaemic activity). The compounds that were effective in inducing cytogenetic effects in lymphocytic leukaemia cells in vivo were also effective in inducing antineoplastic effects in BDF1 mice inoculated with P388 leukaemia cells. These results suggest that the in vivo cytogenetic effects in conjunction with the antineoplastic activity of modified steroidal alkylators depend on the configuration of the whole molecule and on the appropriate combination of the alkylator with the steroidal molecule: a pronounced cytogenetic and anti-neoplastic action was demonstrated by the compounds that contain either PHE or CHL as alkylators and are esterified with either a steroidal nucleus that carries a cholesten group in the 17 position of the D-ring, or with a steroidal nucleus having an exocyclic NHCO-group in the D-ring. In contrast, a ketone group or an NHCO-group in the D-ring inserted endocyclically in the steroidal nucleus esterified with either CHL or PHE failed to induce cytogenetic or anti-neoplastic effects.


Assuntos
Alquilantes/uso terapêutico , Antineoplásicos Alquilantes/uso terapêutico , Antineoplásicos/uso terapêutico , Leucemia P388/tratamento farmacológico , Animais , Antineoplásicos/química , Proliferação de Células/efeitos dos fármacos , Ensaios de Seleção de Medicamentos Antitumorais , Leucemia P388/genética , Camundongos , Compostos de Mostarda Nitrogenada/química , Troca de Cromátide Irmã/efeitos dos fármacos , Esteroides
5.
J BUON ; 15(3): 568-71, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20941829

RESUMO

PURPOSE: The purpose of the present study was the investigation of antileukemic effect of amiodarone in leukemia P388 BDF1 bearing mice and its genotoxic and cytostatic effect in cultured normal human lymphocytes. METHODS: Leukemia P388 was used in this study. BDF1 mice were used for chemotherapy evaluation in vivo. The antitumor activity was assessed by the oncostatic parameter T/C, representing the increase of life span of drug-treated animals vs. controls. Lymphocyte cultures were used to study the genotoxic and cytostatic effect in vitro, expressed by enhanced sister chromatid exchange (SCE) and reduced proliferation rate indices (PRIS). RESULTS: Amiodarone was found to exert antileukemic potency against leukemia P388 bearing mice at all three different treatment schedules used, yielding T/C values of 155%, 163% with one cure and 230%. In the in vitro cytogenic experiments, significant increase of SCE rates by amiodarone was observed at 0.2 µM, while at the same concentration significant suppression of PRIS was achieved. CONCLUSION: According to the National Cancer Institute (NCI), a compound is characterized as potential chemotherapeutic deserving further evaluation if it produces T/C values≥125%. On the other hand the SCE assay has predictive value as a clinical assay for drugs exhibiting a strong correlation between cell killing and induction of SCEs. Further studies are warranted to clarify the structure-activity relationship of amiodarone.


Assuntos
Amiodarona/uso terapêutico , Leucemia P388/tratamento farmacológico , Animais , Proliferação de Células/efeitos dos fármacos , Feminino , Leucemia P388/genética , Leucemia P388/patologia , Camundongos , Camundongos Endogâmicos DBA , Troca de Cromátide Irmã
6.
Food Chem Toxicol ; 48(1): 242-9, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19819285

RESUMO

Erythropoietin (EPO) is a protein widely used against drug induced anemia at cancer patients. Irinotecan (CPT-11) is a genotoxic topoisomerase I inhibitor. We investigated the genotoxic, cytostatic and cytotoxic effects of EPO in the presence and in the absence of CPT-11 in human lymphocytes in vitro and in ascites cells of P388 leukemia in vivo. The levels of genotoxicity, cytostaticity and cytotoxicity were evaluated in human lymphocytes in vitro, and in P388 ascites tumor cells in vivo. The results show that EPO is not genotoxic. Unlikely to EPO, CPT-11 caused severe genotoxic, cytostatic and cytotoxic effects by significantly increasing SCE levels and decreasing PRI and MI values in peripheral lymphocytes in vitro and in P388 ascites tumor cells in vivo. Adding EPO in human lymphocyte cultures in vitro and in P388 leukemia bearing mice in vivo in the presence of CPT-11 decreased SCEs levels and increased PRIs and MIs were observed compared with cells treated either in vitro or in vivo with CPT-11 alone, which shows that EPO protected cells from the toxic action of CPT-11. EPO's protective action on human peripheral lymphocytes in vitro and P388 cells in vivo from the topoisomerase I inhibitor CPT-11, lead us to propose it as a geno- and cytoprotective agent.


Assuntos
Antimutagênicos , Antineoplásicos Fitogênicos/antagonistas & inibidores , Antineoplásicos Fitogênicos/toxicidade , Camptotecina/análogos & derivados , Eritropoetina/farmacologia , Leucemia P388/tratamento farmacológico , Linfócitos/efeitos dos fármacos , Mutagênicos/toxicidade , Adolescente , Adulto , Animais , Camptotecina/antagonistas & inibidores , Camptotecina/toxicidade , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Humanos , Técnicas In Vitro , Irinotecano , Leucemia P388/patologia , Camundongos , Mitose/efeitos dos fármacos , Proteínas Recombinantes , Troca de Cromátide Irmã/efeitos dos fármacos , Adulto Jovem
7.
Food Chem Toxicol ; 47(10): 2445-9, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19577607

RESUMO

Irinotecan (camptothecin, CAM) is a topoisomerase-I inhibitor with a well established action in the chemotherapy of colorectal and ovarian cancer. Hematological and intestinal toxicity are commonly noted in patients treated with CAM. In this study, we examined the cytoprotective efficacy of amifostine (ethyol, ETH) against chromosomal damage induced by this drug on cultured peripheral human lymphocytes. Cultured lymphocytes were exposed to CAM (50 and 100 ng/ml of final concentrations) without or with ETH (in concentrations varying between 40 and 800 microg/ml of final culture volume). CAM's genotoxicity was quantified by counting the Sister Chromatid Exchange (SCEs) rate. The mitotic index (MI) and proliferation rate index (PRI) were also assessed. The SCE rate was increased following incubation with CAM, but the combined treatment of CAM with ETH significantly reduced the SCE formation, especially when ETH added at high concentrations. The MIs and PRIs remained also unaltered in cultures with CAM, but MIs were reduced with the combined treatment at high ETH concentrations. Clinical studies are required to assess the predicted benefits from ETH in patients receiving CAM.


Assuntos
Amifostina/farmacologia , Antimutagênicos/farmacologia , Camptotecina/análogos & derivados , Inibidores Enzimáticos/farmacologia , Linfócitos/efeitos dos fármacos , Protetores contra Radiação/farmacologia , Troca de Cromátide Irmã/efeitos dos fármacos , Adolescente , Adulto , Camptotecina/farmacologia , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Reparo do DNA/efeitos dos fármacos , Relação Dose-Resposta a Droga , Antagonismo de Drogas , Humanos , Irinotecano , Masculino , Índice Mitótico , Adulto Jovem
8.
J BUON ; 13(2): 235-9, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18555471

RESUMO

PURPOSE: In earlier studies, this laboratory carried out research on the synthesis and anticancer evaluation of hybrid compounds, which combine two molecules in one such as homo-aza-steroidal esters (HASE) of carboxylic derivatives of N, N-bis (2-chloroethyl) aniline. In this combination, steroidal hormones are employed as carriers for transporting the alkylating agents to specific targeted tissues. Aiming to continue our research, we used alkylating agents, as nitrosoureas, instead of nitrogen mustards. In this work the N-[N- (2-chloroethyl)-N-nitroso-carbomoyl]-L-alanine (CNC-ala) has been used and was bound to 7 newly synthesized modified steroidal esters (carrier molecule) of nitrosourea and the hybrid molecules were tested for antitumor activity against PANO2 murine pancreatic adenocarcinoma. MATERIALS AND METHODS: PANO2 adenocarcinoma was used in this study. C57Bl mice were used for chemotherapy evaluation. The activity was assessed from the inhibition of tumor growth and the oncostatic parameter T/C %. RESULTS: The antitumor activity displayed by 7 hybrid steroidal esters of nitrosourea was quite interesting. It was able to discern 4 of 7 compounds that exhibited considerable antitumor activity, increasing the lifespan of the tumor-bearing mice by inhibiting the tumor growth. CONCLUSION: The comparative study of 7 newly synthesized hybrid steroidal esters of nitrosourea shows that the antitumor effects of compound 7, which has an enlarged (7 carbon atoms) A-lactamic ring and nitrosourea esterified at the position 17, which seems to be the most appropriate for the connection of a DNA cross-linking amino acid derivative is superior.


Assuntos
Antineoplásicos/uso terapêutico , Compostos de Nitrosoureia/uso terapêutico , Neoplasias Pancreáticas/tratamento farmacológico , Esteroides/farmacologia , Adenocarcinoma/tratamento farmacológico , Adenocarcinoma/secundário , Alanina/análogos & derivados , Alanina/química , Animais , Carcinoma Ductal Pancreático/secundário , Avaliação Pré-Clínica de Medicamentos , Feminino , Humanos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Estrutura Molecular , Compostos de Mostarda Nitrogenada/química , Compostos de Nitrosoureia/síntese química , Neoplasias Pancreáticas/patologia , Esteroides/química , Taxa de Sobrevida , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA